Clindesse
- Product NDC
- 45802-042
- 11-digit product format
- 458020042
- Labeler code
- 45802
- Product ID
- 45802-042_ab0a6fe2-5ee0-408c-9e1d-30ce29344d16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clindamycin phosphate
- Dosage form
- CREAM
- Route
- VAGINAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- NDA050793
- Marketing category
- NDA
- Marketing start
- 2015-07-03
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 100 mg/5g
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clindesse
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLINDAMYCIN PHOSPHATE | 100 mg/5g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EH6D7113I8 |
| Rxcui | 309337, 602427 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45802-042 | CLINDESSE (CLINDAMYCIN PHOSPHATE) CREAM [PADAGIS ISRAEL PHARMACEUTICALS LTD] | 11 | Current NDC, Legacy NDC, 4 package rows | 20250207_fe8bb204-f173-44fe-803b-b08f2ec5aa31.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-042-01 | 45802004201 | 1 APPLICATOR in 1 CARTON (45802-042-01) / 5 g in 1 APPLICATOR | 1 applicator | 2015-07-03 | 0000-00-00 | No | No | Current |
| 45802-042-02 | 45802004202 | 1 APPLICATOR in 1 CARTON (45802-042-02) / 5 g in 1 APPLICATOR | 1 applicator | 2015-07-03 | 0000-00-00 | Yes | No | Current |